摘要目的 研究霉酚酸酯(MMF)治疗原发性肾病综合征的疗效及对尿蛋白的影响.方法 选取原发性肾病综合征患者136例,采用随机数字表法分为MMF组和对照组各68例,对照组行常规治疗,MMF组加用霉酚酸酯治疗.两组均连续治疗6个月后进行疗效评价.结果 MMF组总缓解率(82.8％)显著高于对照组(60.6％)(x2=10.86,P＜0.05);两组BUN、血肌酐(Scr)、24h尿蛋白定量均有不同程度降低,MMF组降低更为显著,各项差异具有统计学意义(t =2.50、4.59、11.12,均P＜0.05).两组血清白蛋白均上升,但MMF组升高更明显,差异具有统计学意义(t =3.09,P＜0.05).结论 霉酚酸酯对原发性肾病综合征及尿蛋白具有疗效显著、副反应小、安全可靠等优点,值得临床推广使用.

abstractsObjective To study the effect of mycophenolate mofetil(MMF) on primary nephrotic syndrome and the impact on urinary protein.Methods According to the digital table,136 cases of nephrotic syndrome were randomly divided into MMF group and control group,68 cases in the control group were dealed with conventional treatment,MMF group was treated with MMF.After 6 months,the treatment effects of both groups were evaluated.Results The overall response rate of MMF group was 82.8％,higher than that of control group 60.6％ with statistically significant difference (x2 =10.86,P ＜ 0.05),;Blood urea nitrogen(BUN),serum creatinine(Scr),24 h urinary protein of two groups had varying degree of reduction,the indexes of MMF group decreased even more significant (t =2.50,4.59,11.12,all P ＜ 0.05).Serum albumin of the two groups had risen,but MMF group increased more significantly (t =3.09,P ＜ 0.05).Conclusion The advantages of MMF are significant effect,reduction in side effects,safe and reliable on nephrotic syndrome and urinary protein,which is worthy of clinical use.